3Scan

📍 San Francisco, United States🗓 Founded 2011👥 3 employees💰 Last funded 2014
Biotechnology Research🌐 3scan.com
Website LinkedIn
3Scan is turning tissue biology and histopathology into data science, giving researchers the insights they need to break new ground. A one-stop shop for digital and computational pathology, 3Scan’s KESM produces digital 3D tissue models with micron-scale resolution at 400 times the throughput of traditional microscopes. 3Scan’s data platform enables quantitative image analysis of diseases like cancer, Parkinson’s, Alzheimer’s, and Huntington’s, opening up the potential for new diagnostic and therapeutic solutions. Founded by Todd Huffman, Megan Klimen, Matthew Goodman, and Cody Daniel in San Francisco in 2011, 3Scan’s team of engineers, biologists and data-scientists is expanding its work into a suite of digital tools that will allow instant identification and classification of histopathologic features and tissue structures.
1
Total investors
0
Early stage
1
Mid stage
0
Late stage
2011
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in 3Scan?
3Scan has 1 investors on record on gritt.io, 1 mid-stage.
When did 3Scan last raise funding?
The most recent investment in 3Scan recorded on gritt.io was in 2014.
When was 3Scan founded?
3Scan was founded in 2011.
What industry is 3Scan in?
3Scan operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is 3Scan based?
3Scan is headquartered in San Francisco, United States.